Putting primary prevention of dementia on everybody's agenda.


Journal

Aging & mental health
ISSN: 1364-6915
Titre abrégé: Aging Ment Health
Pays: England
ID NLM: 9705773

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 28 6 2020
medline: 7 8 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

Many publications on dementia start by outlining the current estimated number of people with dementia and how that figure is going to double (in Western societies) or even quadruple (in developing countries) in the coming decades as a result of increasing life expectancy (in itself a good development). Dementia is therefore a huge challenge to society, both in terms of providing good care for persons living with dementia and their family caregivers, as well as in searching for curative solutions. Both these challenges are complex. Fortunately, recent research indicates primary prevention to be a promising additional strategy in the dementia quest. Now that epidemiological research robustly shows the link between lifestyle and risk of dementia, new challenges emerge, such as how to increase public awareness about brain health, how to develop and implement strategies to promote brain healthy lifestyles and how to avoid increasing health inequalities. Interdem, the pan-European network of researchers on Psychosocial Interventions in Dementia, strongly welcomes this new strategy and consequently established a taskforce on primary prevention. In this position paper, we outline what we see as main building blocks of primary prevention of dementia.

Identifiants

pubmed: 32590910
doi: 10.1080/13607863.2020.1783514
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1376-1380

Auteurs

Jan Steyaert (J)

Department of Sociology, University of Antwerp, Antwerpen, Belgium.
Expertisecentrum Dementie Vlaanderen, Antwerpen, Belgium.

Kay Deckers (K)

Department of Psychiatry & Neuropsychology, Alzheimer Centrum Limburg, Maastricht University, Maastricht, The Netherlands.

Carolien Smits (C)

Research Group for Innovations in Care for Older Adults, Windesheim University of Applied Sciences, Zwolle, The Netherlands.

Chris Fox (C)

Norwich Medical School, University of East Anglia, Norwich, United Kingdom.

René Thyrian (R)

German Center for Neurodegenerative Diseases (DZNE), Greifswald, Germany.

Yun-Hee Jeon (YH)

Sydney Nursing School, University of Sydney, Camperdown, Australia.

Myrra Vernooij-Dassen (M)

IQ Healthcare, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Sebastian Köhler (S)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH